| William John Hall, MD | |
|
1000 South Ave, Box 58, Rochester, NY 14620-2733 | |
| (585) 341-6202 | |
| (585) 341-8305 |
| Full Name | William John Hall |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 1000 South Ave, Rochester, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174630933 | NPI | - | NPPES |
| 00488202 | Medicaid | NY | |
| 100630BJ | Other | NY | PREFERRED CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 11847 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William John Hall, MD 1000 South Ave, Box 58, Rochester, NY 14620-2733 Ph: (585) 341-6202 | William John Hall, MD 1000 South Ave, Box 58, Rochester, NY 14620-2733 Ph: (585) 341-6202 |
News Archive
Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.
Mercy Medical Center, a nationally recognized medical facility, has announced the installation of five premium Resona 7 ultrasound machines from Mindray for the hospital's Vascular Center, Paul R. Lucas, M.D., FACS, RPVI, Director, The Vascular Center at Mercy has announced.
A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute report in the Oct. 28 issue of the New England Journal of Medicine.
There is new hope in the fight against Huntington's disease. Scientists at the Gladstone Institutes discovered that changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral symptoms in a mouse model of the disease.
› Verified 7 days ago
Amy Bodrog, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |